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It is well documented that individuals with compromised immunity have an increased risk of 10 
foodborne infection; however, many often do not have an awareness that they are more vulnerable to 11 
foodborne infection. Consequently, such individuals need to be made aware of their increased risk and 12 
of food safety practices necessary to reduce the potential risk of foodborne disease. Consumer food 13 
safety research suggest highly focused, targeted interventions are the most impactful for effective 14 
consumer food safety education. Interventions that enable immunocompromised individuals to 15 
understand their increased susceptibility to infection may empower this vulnerable group to adopt risk 16 
reducing food safety practices. The aim of this paper is to explore the association between foodborne 17 
infection and diabetes mellitus to increase understanding of this under-represented group within food 18 
safety research. Findings may help inform the development of future food safety educational 19 
interventions specifically intended for people living with diabetes mellitus.  20 
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OVERVIEW  21 
Who are the vulnerable groups at an increased risk of foodborne infection? 22 
Although foodborne infection can affect anyone, current advice about the risks of contracting 23 
foodborne infection tend to focus on specific populations who are considered particularly vulnerable 24 
(26). In countries such as the United Kingdom and United States, it is suggested that 20% of the 25 
population may be more susceptible to foodborne infection compared with the general population 26 
(34). Consumer food safety research often identifies vulnerable groups as pregnant women, children, 27 
older adults and immunocompromised individuals (16, 55). Susceptibility can result from chronic or 28 
acute illness, medication (33), and/or immunosenescence (age-related deterioration in immune 29 
responses) (2, 6). 30 
There is no doubt that substantial proportions of immunocompromised people have increased 31 
susceptibility to foodborne illness compared with non-immunocompromised people (33); as data 32 
shows that infection rates of notifiable foodborne infectious diseases such as campylobacteriosis, 33 
listeriosis and salmonellosis are higher among such groups (7, 46). Immunocompromised individuals 34 
are vulnerable to foodborne infection as enteric pathogens can take advantage of impaired immune 35 
system to set up persistent and generalized infections in the immunocompromised host (16). These 36 
foodborne infections are some of the most challenging for healthcare providers to treat as they tend to 37 
be long term, add to the burden of debilitation in the patient, and can result in a significant higher 38 
mortality rate than non-immunocompromised persons (16). 39 
Classifying immunocompromised groups for food safety education.  40 
Health promotion interventions aim to engage and empower individuals to choose health 41 
promoting or risk reducing behaviours (39), such approaches can be utilized by food safety educators 42 
to deliver food safety information. Although awareness-raising among vulnerable population groups 43 
are required to reduce the risk of foodborne infection within the immunocompromised population 44 
(56), it may be necessary for food safety educators to adopt a targeted approach when considering 45 
food safety education interventions for immunocompromised patients (36). Immunocompromised 46 
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populations are under-represented as targets of food safety interventions (50). Furthermore, the large 47 
variability of persons classed as immunocompromised may limit the ability for food safety educators 48 
to provide effective food safety interventions.  49 
Persons classed as immunocompromised and associated with a greater risk of foodborne infection 50 
include: pregnant women (46), people that have undergone organ transplants (41), those on 51 
medications that interfere with immune function (e.g. cytotoxic drugs for the treatment of cancer (43) 52 
or disease modifying drugs for active relapsing remitting multiple sclerosis (24)), people with auto-53 
immune diseases (48) (e.g. multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis and 54 
lupus) or people with conditions that impact immune function (e.g. diabetes mellitus (4), HIV/AIDS 55 
(23, 28)). Classifying all immunocompromised individuals within a one-size fits all approach, may not 56 
be appropriate or effective in conveying accurate food safety advice, particularly as needs and 57 
circumstances will vary greatly between individual groups (32). It may be necessary to identify and 58 
target vulnerable populations at risk of foodborne infection according to specific underlying 59 
conditions of diseases. 60 
Diabetes mellitus and risk of foodborne infection. 61 
One vulnerable group known to have an increased risk of foodborne infection, which tend to be 62 
overlooked within the food safety literature are individuals with diabetes (49). Diabetes mellitus is a 63 
serious, chronic disease characterized by hyperglycaemia (raised blood glucose levels), that occurs 64 
either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or 65 
glucose) (type 1 diabetes), or when the body cannot effectively use the insulin it produces (type 2 66 
diabetes) (57). The prevalence of diabetes has been steadily increasing worldwide over the past few 67 
decades, with current data outlined in Table 1. Current trends indicate that the estimated worldwide 68 
prevalence of the condition is set to rise by 20% over the next 10 years (47). Aging of the overall 69 
population is reported to be a significant driver of the diabetes epidemic (29). 70 
Diabetes is often wrongly assumed to be condition affecting only blood glucose levels and result in 71 
minimal health consequences (35). However, diabetes can affect the majority of organs within the body, 72 
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leading to a number of complications (see Table 2). Diabetes complications can be divided into those 73 
caused due to damage to the microvascular (small blood vessels) or macrovascular (larger blood 74 
vessels) system (8, 58).  75 
From the available data it is suggested that people with diabetes are at increased risk of foodborne 76 
infection (20, 38, 40, 51, 52). During a Salmonella enteritidis outbreak in a hospital setting, a case-77 
control study reported that patients with diabetes, who required medication to control their blood 78 
glucose levels (insulin or oral hypoglycaemics), were more likely to develop salmonellosis (52). 79 
Similarly, Neal and Slack (40) studied notified cases of Campylobacter gastroenteritis in adults over 80 
a 14-month period in the UK, and found that diabetes mellitus increases the risk of 81 
campylobacteriosis, similar to that seen with salmonellosis. Risk of listeriosis is also suggested to be 82 
elevated among people with diabetes (51). Mook et al., (38) reported that diabetes increased the risk 83 
for serious infection from Listeria monocytogenes, with patients with diabetes having an 11-fold 84 
increased risk for development of listeriosis. Even greater risk of infection with listeriosis was 85 
suggested by Goulet and Marchetti (20), who stated that patients with insulin-dependent diabetes were 86 
25 times more likely to develop listeriosis than healthy, non-diabetic patients.  87 
It is also important to consider that aside from the increased risk of foodborne infection in people 88 
with diabetes, the symptoms associated with foodborne infection could trigger life threatening 89 
diabetes mellitus complications in this vulnerable group. Excessive vomiting can lead to 90 
hypoglycaemia (drop in blood glucose levels) which can be abrupt, and if left untreated, could lead to 91 
blurred vision, slurred speech, confusion, and even loss of consciousness (11). Diabetic ketoacidosis 92 
is another potentially dangerous condition that may develop in people with diabetes as a result of 93 
foodborne infection (37). Diabetic ketoacidosis is most commonly associated with type 1 diabetes and 94 
occurs when the body has insufficient insulin to allow enough glucose to enter cells, and so the body 95 
switches to burning fatty acids and producing acidic ketone bodies (12). A high level of ketone bodies 96 
in the blood can cause particularly severe illness including coma or even death, if it is not treated 97 
quickly (1). 98 
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Why are people with diabetes at an increased risk of foodborne infection?  99 
The increased risk of foodborne infection among people with diabetes is likely due to autonomic 100 
neuropathy, in which elevated blood glucose causes damage to nerves that control involuntary bodily 101 
functions including digestion (53). Within the digestive system, autonomic neuropathy may result in 102 
gastroparesis, a condition in which reduced smooth muscle control slows or stops the movement of 103 
food from the stomach to the small intestine (25). The resultant prolonged gastrointestinal transit time 104 
can give harmful bacteria time to multiply and grow (30). Gastroparesis is thought to affect 20–50% 105 
of the diabetic population, and is especially common in those with type 1 diabetes, or those with long-106 
standing (>10 years) type 2 diabetes (3). Gastric acid production, responsible for the breakdown of 107 
food and beverages in the stomach, may also be reduced. As the hydrochloric acid functions as a 108 
barrier to ingested bacteria, this would limit the ability of the stomach to act as a barrier to ingested 109 
bacteria (17).  110 
Glycaemic control (typical blood glucose levels) seems to be an important risk factor in increased 111 
susceptibility of infection in people with diabetes. Poor glycaemic control is powerfully associated 112 
with serious infections (9). A review of epidemiological studies found clinically important (∼1.5–3.5 113 
times higher) infection risks associated with poorer glycaemic control (45). Poor glycaemic control is 114 
associated with impaired neutrophil function (27), which are known to be important in the early stages 115 
of the immune response to foodborne infection (10). Therefore, how well an individual manages their 116 
diabetes and maintains their blood glucose levels may impact on their risk of foodborne infection. In 117 
particular, those individuals with type 1 diabetes, have been found to have increased rates of poor 118 
glycaemic control (9), and may be at approximately double the risk of infection compared to those 119 
with type 2 diabetes (5). Poor glycaemic control among individuals with type 1 diabetes has also been 120 
associated with low socioeconomic status, depression and is more likely to occur in young adults (22, 121 
31). 122 
How to reduce the risk of foodborne infection among people with diabetes?  123 
Considering the number of people with diabetes worldwide, the increased risk of foodborne 124 
infection, and the potential life-threatening complications associated with foodborne infection; 125 
patients with diabetes may be considered an important group to target in the context of food safety 126 
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education. Engagement with this vulnerable group and promotion of food safety education is of 127 
particular importance. It has been reported that people with diabetes often do not have an awareness 128 
that they are at increased risk of foodborne infection (15). It is common for individuals to demonstrate 129 
optimistic bias and personal invulnerability; whereby the risk is perceived to be greater to others (14). 130 
Consequently, food safety education initiatives may be overlooked as they are perceived to be aimed 131 
at those that are at greater risk than themselves (44).  132 
Given the importance of attitudes in relation to behavior change (42), targeted interventions need 133 
to address individual’s perceptions of risk, control and responsibility for foodborne infection (14). 134 
Interventions need to demonstrate ‘why’ these individuals are more susceptible to foodborne 135 
infection, highlight ‘what’ practices need to be followed, and ‘how’ engagement with the 136 
recommended practices will be beneficial in reducing the associated risks. Enabling individuals with 137 
diabetes to ‘risk assess’ and determine if they are going to engage with risk reducing behaviors should 138 
be encouraged. Indeed, constructs of the Health Belief Model (18) should be considered in the 139 
development of targeted interventions. For example, if individuals regard themselves as being 140 
susceptible to foodborne infection, believe that it would have potentially serious consequences, 141 
believe that action would be beneficial in reducing the risk, and believe the anticipated benefits of 142 
taking action outweigh the potential barriers, they may be more likely to engage with the 143 
recommended action. 144 
Such interventions should be designed through co-creation with individuals with diabetes and key 145 
stakeholders. Co-creation is essential to enhance the credibility and suitability of the intervention, due 146 
to the involvement of the intended target audience in the design, development and evaluation of the 147 
intervention (21, 32). Interventions should also be delivered by trusted sources for information such as 148 
healthcare professionals that are commonly involved in the care and treatment of people with 149 
diabetes. Wohlgenant et al. (54) reported that healthcare providers (including physicians, registered 150 
nurses, nurse practitioners, physician assistants and home healthcare providers) perceive food safety 151 
education to be important. However, such healthcare providers lack sufficient training and knowledge 152 
or the willingness to provide food safety information (54). There is a need to determine who the key 153 
healthcare professionals are that are regularly seen and trusted by people living with diabetes, to 154 
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explore their food safety training, awareness of patient group susceptible to foodborne infection and 155 
attitudes towards the provision of food safety education. There is a need to integrate food safety 156 
education into preventive healthcare (19, 54). 157 
There is a need for future research to determine if the educational needs of patients living with 158 
type 1 diabetes are different to those living with type 2 diabetes, due to the increased risk of infection 159 
associated with type 1 diabetes. There is also a need to consider the different demographic 160 
characteristics of people that have diabetes, due to the variation within the patient group. In addition, 161 
the importance of glycaemic control may also need to be incorporated into food safety education 162 
considering the link between glycaemic control and risk of foodborne infection in individuals with 163 
diabetes.  164 
Conclusions. 165 
Individuals with diabetes are at increased risk of foodborne infection, that along with potential 166 
life-threatening complications associated with foodborne infection, make this a particularly vulnerable 167 
group in the context of food safety education. Identifying and communicating specifically-targeted 168 
and highly-focused food safety education interventions to individuals with diabetes, may help 169 
promote more positive food safety attitudes and enable implementation of appropriate food safety 170 
behaviours to reduce the risk of foodborne infection. Furthermore, raising awareness of the 171 
association between diabetes and foodborne infection may increase patient understanding of the 172 
perceived risk to themselves, and increase engagement with risk reducing food safety behaviours.  173 
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Table 1 Estimated prevalence of individuals with diabetes in USA, UK and worldwide in 2019 331 
and 2030. 332 
Country 
Estimated prevalence of individuals with diabetes 
Source 
2019 2030 
USA 31 million 34 million (47) 
UK 3.8 million 5.5 million (13) 
Worldwide 463 million 578 million (47) 
  333 
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Table 2 Complications of diabetes adapted from World Health Organization (58) and Chawla et 334 









A leading cause of blindness and visual disability caused by 
small blood vessel damage to the back layer of the eye 
(retina), leading to progressive loss of vision.  
Nephropathy 
(kidney disease) 
Caused by damage to small blood vessels in the kidneys and 
can lead to kidney failure, and possibly death. In developed 




Damage to peripheral nerves within the body which may result 
in pain, burning or a loss of sensation (sensory neuropathy), or 
can cause loss of control of internal organs and include 






Blood vessels may be damaged through “atherosclerosis”, or 
blocking of arteries with fatty plaques. This narrowing of 
arteries can lead to decreased blood flow to heart muscle 
(causing a heart attack), to the brain (leading to stroke), or to 
extremities that may lead to pain (claudication) and decreased 
healing of infections.  
Foot disease Results due to reduction in blood flow and neuropathy to the 
lower limb that can lead to lead to ulceration and subsequent 
limb amputation.  
 336 
